12 February 2021
Latham & Watkins Advises the Underwriters in Talis Biomedical’s Initial Public Offering
Advising firms
Deal team
14 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Brian Cuneo Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Miles Jennings Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Ken Hagan | Latham & Watkins LLP | Associate | corporate | Not stated |
| Raul Gonzalez | Latham & Watkins LLP | Associate | corporate | Not stated |
| John Manthei | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Heather Deixler | Latham & Watkins LLP | Counsel | FDA regulatory | Bay Area |
| Betty Pang | Latham & Watkins LLP | Counsel | FDA regulatory | Bay Area |
| Barrett Tenbarge | Latham & Watkins LLP | Associate | FDA regulatory | Not stated |
| Chris Hazuka | Latham & Watkins LLP | Partner | intellectual property | Bay Area |
| Brendan Haberle | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Ashley Wagner | Latham & Watkins LLP | Partner | benefits and compensation | Bay Area |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Amy Feinberg | Latham & Watkins LLP | Associate | tax | Not stated |
11 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 221m (US$220.8 million)
- What the figure measures
- Issue size
- Client
- Latham & Watkins LLPUnderwriters
- Counterparties
- Talis Biomedical Corporation (Issuer)